Neumora Therapeutics Ownership | Who Owns Neumora Therapeutics?
Neumora Therapeutics Ownership Summary
Neumora Therapeutics is owned by 34.68% institutional investors, 27.53% insiders, and 37.79% retail investors. Softbank group is the largest institutional shareholder, holding 4.05% of NMRA shares.
NMRA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Neumora Therapeutics | 34.68% | 27.53% | 37.79% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Softbank group | 6.54M | 4.05% | $4.80M |
| Mic capital management uk llp | 4.46M | 2.76% | $3.27M |
| Siren | 4.36M | 2.70% | $3.20M |
| Wellcome trust ltd (the) as trustee of the wellcome trust | 3.31M | 2.05% | $2.43M |
| Blackrock funding, inc. /de | 2.88M | 1.78% | $2.11M |
| Iconiq capital | 2.56M | 1.58% | $1.88M |
| T. rowe price investment management | 2.10M | 1.30% | $1.54M |
| Johnson & johnson | 1.85M | 1.14% | $1.40M |
| Tang capital management | 1.40M | 0.87% | $1.03M |
| Baker bros. advisors lp | 1.03M | 0.64% | $758.67K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mic capital management uk llp | 4.46M | 0.64% | $3.27M |
| Johnson & johnson | 1.85M | 0.42% | $1.40M |
| Siren | 4.36M | 0.17% | $3.20M |
| Addis & hill | 163.39K | 0.08% | $119.81K |
| Tang capital management | 1.40M | 0.05% | $1.03M |
| Iconiq capital | 2.56M | 0.03% | $1.88M |
| Wellcome trust ltd (the) as trustee of the wellcome trust | 3.31M | 0.03% | $2.43M |
| Softbank group | 6.54M | 0.02% | $4.80M |
| Skyoak wealth | 100.00K | 0.01% | $73.33K |
| Baker bros. advisors lp | 1.03M | 0.01% | $758.67K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Acadian asset management | 668.09K | 0.00% | 648.41K |
| Marshall wace, llp | 250.49K | 0.00% | 250.49K |
| Rbf capital | 160.00K | 0.01% | 160.00K |
| Skyoak wealth | 100.00K | 0.01% | 100.00K |
| Y-intercept (hong kong) | 57.07K | 0.00% | 57.07K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | - | - | -3.70M |
| Blackrock funding, inc. /de | 2.88M | - | -3.47M |
| Ecor1 capital | - | - | -2.07M |
| Rock springs capital management lp | - | - | -955.11K |
| Orbimed advisors | - | - | -805.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Marshall wace, llp | 250.49K | 0.00% | 250.49K | $182.86K |
| Rbf capital | 160.00K | 0.01% | 160.00K | $117.33K |
| Y-intercept (hong kong) | 57.07K | 0.00% | 57.07K | $41.85K |
| Canada pension plan investment board | 55.70K | - | 55.70K | $40.84K |
| Hrt financial lp | 45.06K | 0.00% | 45.06K | $33.00K |
Sold Out
| Holder | Change |
|---|---|
| Advisor group | -6.00 |
| Gamma investing | -16.00 |
| Ronald blue trust | -38.00 |
| Lindbrook capital | -48.00 |
| Corecap advisors | -57.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 100 | -13.79% | 56,072,937 | -7.73% | 34 | 2.45% | 50 | -20.63% | 30 | -6.25% |
| Mar 31, 2025 | 116 | -27.95% | 65,233,669 | -16.60% | 40 | 1.68% | 62 | -31.11% | 32 | - |
| Dec 31, 2024 | 164 | 43.86% | 80,367,336 | 17.21% | 50 | 2.73% | 92 | 53.33% | 33 | 57.14% |
| Sep 30, 2024 | 114 | 18.75% | 68,568,182 | 7.43% | 42 | 2.67% | 60 | -10.45% | 21 | 61.54% |
| Jun 30, 2024 | 96 | 9.09% | 63,827,345 | 21.38% | 40 | 3.62% | 67 | 28.85% | 13 | -23.53% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 18, 2025 | BERNS PAUL L | See Remarks | Sell | $23.47K |
| Feb 18, 2025 | Milligan Michael Lee | See Remarks | Sell | $3.35K |
| Feb 18, 2025 | Aurora Daljit Singh | Chief Strategy Officer | Sell | $14.35K |
| Feb 18, 2025 | Lenz Robert A. | Head of R&D | Sell | $9.38K |
| Feb 18, 2025 | Pinto Joshua | President | Sell | $13.48K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 5 |
| 2024 Q4 | - | 4 |
| 2024 Q3 | - | 3 |
| 2023 Q4 | 20 | - |
NMRA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools